Trial Search Results
Ambulatory Alcohol Detoxification With Remote Monitoring
This study is designed to examine the feasibility and impact of the use of remote monitoring devices during an outpatient ambulatory alcohol detoxification treatment for patients with alcohol use disorders.
Stanford is currently accepting patients for this trial.
Collaborator: SoberLink, LLC
- Device: Remote Monitoring with Ambulatory Detox
- Male or female Subject between the ages of 21-75 years old
- Meeting DSM-V criteria for alcohol use disorder and needing medically supervised
detoxification based on medical history and pattern of alcohol use delineated by
timeline follow back method.
- Has 24/7 easy access to a hospital. This is to ensure easy admission to a higher level
of care if indicated.
- Willing to use the Soberlink Device to provide blood alcohol concentration (BAC)
- Willing to use the blood pressure cuff to provide blood pressure and pulse (BPPT)
- Willing to sign an informed consent
- BAC above the legal driving limit at the time of screening
- Developing symptoms or history of symptoms of severe withdrawal syndrome such as
fever, disorientation, drenching sweats, severe tachycardia, or severe hypertension
- History of delirium tremens or seizures
- Co-morbid medical or psychiatric history requiring inpatient admission for careful
- Subject unwilling to respond to redirection when blood pressure and heart rate warning
signs are triggered
- Does not have an iPhone, iPod, iPad, or Apple Watch with iOS 7.0 or later, or does not
have an Android phone or tablet with Android 4.4 or later
- Unable or unwilling to properly use the monitoring devices, or find the monitoring
devices an obstruction to comply with treatment
- Subject that is non-English speaking
- Subject that is a child, adolescent, or cognitively impaired
Ages Eligible for Study
21 Years - 75 Years
Genders Eligible for Study